The results of H&E staining indicated that the xenografts carrying USP10 shRNA LN229 and GBM2 cells displayed restricted tumor growth, whereas this effect was reversed by overexpression of RUNX1 (Fig. 3I). This evidence concerns the gene RUNX1 and neoplasm.